Editorial Commentary: Are We Ready to Apply Stem Cell Therapy in Rotator Cuff Tear Surgery?

Hajime Utsunomiya; Ichiro Sekiya; Soshi Uchida

doi:10.1016/j.arthro.2019.09.001

Editorial Commentary: Are We Ready to Apply Stem Cell Therapy in Rotator Cuff Tear Surgery?

Arthroscopy. 2020 Jan;36(1):86-87. doi: 10.1016/j.arthro.2019.09.001.

Authors

Hajime Utsunomiya¹, Ichiro Sekiya¹, Soshi Uchida¹

Affiliation

¹ Wakamatsu Hospital of University of Occupational and Environmental Health, Tokyo Medical and Dental University.

PMID: 31864604
DOI: 10.1016/j.arthro.2019.09.001

Abstract

For rotator cuff tear surgery, application of mesenchymal stem cells (MSCs) is a promising new option. Among various MSC sources, synovial tissue contains a high number of MSCs with high chondrogenic potential. Because chondrogenic formation is an important factor in enthesis healing in rotator cuff repair, synovial MSCs derived from the subacromial bursa are superior candidates for the augmentation of rotator cuff tear surgery.

Publication types

Editorial
Comment

MeSH terms

Arthroplasty
Bursa, Synovial
Humans
Rotator Cuff / surgery*
Rotator Cuff Injuries / surgery*
Shoulder